Clinical Trial: PREDICT-DM: Community Pharmacy-Based Point-of-Care Testing for Undiagnosed T2DM

U.S., Sept. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07795918) titled 'PREDICT-DM: Community Pharmacy-Based Point-of-Care Testing for Undiagnosed T2DM' on Aug. 26.

Brief Summary: The goal of this observational study is to learn whether community pharmacy-based risk assessment and point-of-care HbA1c testing can help detect undiagnosed type 2 diabetes and prediabetes among adults in Irbid Governorate, Jordan, who have no previous diabetes diagnosis.

The main questions it aims to answer are:

What proportion of participants fall into each Finnish Diabetes Risk Score category? What proportion of participants at high or very high risk have HbA1c results within the prediabetes or diabetes range?

Participa...